✦ LIBER ✦

Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease

✍ Scribed by B. Caronti; G. Antonini; C. Calderaro; S. Ruggieri; G. Palladini; F. E. Pontieri; C. Colosimo

Publisher: Springer
Year: 2001
Tongue: English
Weight: 53 KB
Volume: 108
Category: Article
ISSN: 1435-1463
DOI: 10.1007/s007020170030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine transporter immunoreactivity in

Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson’s disease from essential tremor

✍ C. Pellicano; F. R. Buttarelli; A. Circella; D. Tiple; M. Giovannelli; D. Beninc 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 65 KB

Dopamine transporter immunoreactivity in

Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy

✍ Francesca R. Buttarelli; Annapia Circella; Clelia Pellicano; Dorina Tiple; Moren 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB

The dopamine transporter: Importance in

The dopamine transporter: Importance in Parkinson's disease

✍ John G. Nutt; Julie H. Carter; Gary J. Sexton 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Higher dopamine transporter density in P

Higher dopamine transporter density in Parkinson’s disease patients with depression

✍ Andre C. Felicio; Tais S. Moriyama; Clecio Godeiro-Junior; Ming C. Shih; Marcelo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 132 KB

The effect of dopamine agonist therapy o

The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease

✍ J. Eric Ahlskog; Ryan J. Uitti; Michael K. O'Connor; Demetrius M. Maraganore; Jo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Increased expression of dopamine recepto

Increased expression of dopamine receptors on lymphocytes in Parkinson's disease

✍ Piero Barbanti; Giovanni Fabbrini; Alberto Ricci; Rosanna Cerbo; Elena Bronzetti 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Dopamine D1-like and D2-like receptors on peripheral blood lymphocytes (PBL) were assayed in 50 de novo patients with idiopathic Parkinson's disease (PD), in 36 neurologic control subjects (multiple-system atrophy, n ‫ס‬ 16; essential tremor, n ‫ס‬ 10; other neurodegenerative diseases, n ‫ס‬ 10), an